3650 results for «248»
3650 results
Clinical cases - Coronary interventions - Session 2
06 Oct 2022 – From AICT-AsiaPCR 2022
Abstracts - Coronary interventions - Session 2
06 Oct 2022 – From AICT-AsiaPCR 2022
Abstracts - Coronary interventions - Session 3
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 4
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 5
07 Oct 2022 – From AICT-AsiaPCR 2022
Outcome of women in different cardiovascular interventions
06 Oct 2022 – From AICT-AsiaPCR 2022
Spontaneous coronary artery disease, INOCA, MINOCA in women
21 Sep 2023 – From AICT-AsiaPCR 2023
Consult this session to better understand the causes of myocardial infarction without obstructive disease (MINOCA), to revisit ischemia with no obstructive coronary atherosclerosis (INOCA), and to broaden your understanding of spontaneous coronary artery dissection (SCAD) beyond its association with pregnancy.
Next-gen complex interventional techniques and solutions
21 Sep 2023 – From AICT-AsiaPCR 2023
Join us in this session where experts delve into advanced techniques for complex interventions: discover tips for PCI without metallic stents, explore novel tools for bifurcation and complex lesions, and learn from clinical experiences in managing long diffused lesions.
RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure
01 Sep 2024
Nicola Ryan provides her take on the RESHAPE-HF2 trial presented by Stefan Anker at the ESC Congress 2024 in London and simultaneously published in the NEJM.
The RESHAPE-HF 2 trial is a prospective randomised control trial comparing transcatheter mitral valve repair (TEER) and guideline-directed medical therapy to guideline-directed medical...
Author
Insights from the Corevalve US Pivotal and SURTAVI trials
05 Apr 2022
Pierre Deharo and Giuseppe Di Gioia provide their take on this analysis of the 5 years incidence, outcomes and predictors of hemodynamic SVD in patients undergoing TAVI and surgery from the Corevalve US Pivotal and SURTAVI trials.
Author
Author
